SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
机灵的冷之
Lv1
90 积分
2023-08-16 加入
最近求助
最近应助
互助留言
The GM–CSF/IL‐3/IL‐5 cytokine receptor family: from ligand recognition to initiation of signaling
21小时前
已完结
mTORC1 Status Dictates Tumor Response to Targeted Therapeutics
1个月前
已完结
Orthoallosteric EGFR‐TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S Mutation
1个月前
已完结
Discovery and preclinical evaluations of drug candidate DA-0157 capable of overcoming EGFR drug-resistant mutation C797S and EGFR/ALK co-mutations
1个月前
已完结
P3.12D.03 A Study to Investigate Safety, PK, And Anti-Tumor Activity of TRX-221 In EGFR Mutant NSCLC: TRX-221-001 In Progress
3个月前
已完结
Deciphering the ferroptosis pathways in dorsal root ganglia of Friedreich ataxia models. The role of LKB1/AMPK, KEAP1, and GSK3β in the impairment of the NRF2 response
6个月前
已完结
NRF2 Inhibitors: Recent Progress, Future Design and Therapeutic potential
6个月前
已完结
A core NRF2 gene set defined through comprehensive transcriptomic analysis predicts selective drug resistance and poor multi-cancer prognosis
8个月前
已完结
CTNI-03. EFFICACY OF WSD0922-FU IN OSIMERTINIB-RESISTANT NSCLC WITH CENTRAL NERVOUS SYSTEM (CNS) METASTASES – UPDATES FROM THE DOSE ESCALATION COHORT OF A FIRST-IN-HUMAN PHASE 1 CLINICAL TRIAL (MC1914)
8个月前
已完结
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
11个月前
已完结
没有进行任何应助
感谢
21小时前
感谢
1个月前
感谢
1个月前
感谢
1个月前
感谢
3个月前
感谢
6个月前
感谢
8个月前
感谢
11个月前
感谢
11个月前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论